{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T10:22:45Z","timestamp":1788603765435,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.urolonc.2021.05.032","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T09:37:28Z","timestamp":1627033048000},"page":"730.e9-730.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A multidisciplinary team-based approach with lifestyle modification and symptom management to address the impact of androgen deprivation therapy in prostate cancer: A randomized phase II study"],"prefix":"10.1016","volume":"39","author":[{"given":"YaoYao","family":"Pollock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey A.","family":"Kenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"Van Blarigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Rodvelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rabow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Macaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Topp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Hough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Paciorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June M.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.urolonc.2021.05.032_bib0001","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/cncr.21642","article-title":"Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy","volume":"106","author":"Basaria","year":"2006","journal-title":"Cancer"},{"issue":"24","key":"10.1016\/j.urolonc.2021.05.032_bib0002","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2006.05.9741","article-title":"Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy","volume":"24","author":"Braga-Basaria","year":"2006","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.urolonc.2021.05.032_bib0003","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1002\/cncr.24283","article-title":"Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer","volume":"115","author":"Taylor","year":"2009","journal-title":"Cancer"},{"issue":"17","key":"10.1016\/j.urolonc.2021.05.032_bib0004","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1200\/JCO.2001.19.17.3750","article-title":"Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study","volume":"19","author":"Potosky","year":"2001","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.032_bib0005","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1464-410X.2008.08156.x","article-title":"Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer","volume":"103","author":"Panju","year":"2009","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.032_bib0006","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1464-410X.2012.11774.x","article-title":"Androgen deprivation therapy: evidence-based management of side effects","volume":"111","author":"Ahmadi","year":"2013","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.032_bib0007","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2021.05.032_bib0008","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/pcan.2012.52","article-title":"Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: a randomized controlled trial","volume":"16","author":"Cormie","year":"2013","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.urolonc.2021.05.032_bib0009","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1200\/JCO.2009.23.2488","article-title":"Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial","volume":"28","author":"Galv\u00e3o","year":"2010","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.urolonc.2021.05.032_bib0010","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1200\/JCO.2003.09.534","article-title":"Resistance exercise in men receiving androgen deprivation therapy for prostate cancer","volume":"21","author":"Segal","year":"2003","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.032_bib0011","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/annonc\/mdn644","article-title":"A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB)","volume":"20","author":"Loprinzi","year":"2009","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.urolonc.2021.05.032_bib0012","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1464-410X.2011.10555.x","article-title":"A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy","volume":"109","author":"Nobes","year":"2012","journal-title":"BJU Int"},{"issue":"8","key":"10.1016\/j.urolonc.2021.05.032_bib0013","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMoa0809003","article-title":"Denosumab in men receiving androgen-deprivation therapy for prostate cancer","volume":"361","author":"Smith","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.032_bib0014","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/bju.14086","article-title":"Clinical pathway improves implementation of evidence-based strategies for the management of androgen deprivation therapy-induced side effects in men with prostate cancer","volume":"121","author":"Bultijnck","year":"2018","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.032_bib0015","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.2047-2927.2013.00093.x","article-title":"Cardiovascular risk and bone loss in men undergoing androgen deprivation therapy for non-metastatic prostate cancer: implementation of standardized management guidelines","volume":"1","author":"Cheung","year":"2013","journal-title":"Andrology"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.032_bib0016","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ajcn\/47.1.7","article-title":"Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study","volume":"47","author":"Segal","year":"1988","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.032_bib0017","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12603-011-0085-6","article-title":"Comparing measures of fat-free mass in overweight older adults using three different bioelectrical impedance devices and three prediction equations","volume":"16","author":"Ramsey","year":"2012","journal-title":"J Nutr Health Aging"},{"issue":"11","key":"10.1016\/j.urolonc.2021.05.032_bib0018","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/oby.2006.241","article-title":"Comparison of three bioelectrical impedance methods with DXA in overweight and obese men","volume":"14","author":"Pateyjohns","year":"2006","journal-title":"Obesity"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.032_bib0019","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1017\/S0007114508925460","article-title":"Validity and reliability of body composition analysers in children and adults","volume":"100","author":"Jensky-Squires","year":"2008","journal-title":"Br J Nutr"},{"issue":"9","key":"10.1016\/j.urolonc.2021.05.032_bib0020","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"18","key":"10.1016\/j.urolonc.2021.05.032_bib0021","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. patient health questionnaire","volume":"282","author":"Spitzer","year":"1999","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.urolonc.2021.05.032_bib0022","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/pon.1729","article-title":"The Attentional Function Index\u2013a self-report cognitive measure","volume":"20","author":"Cimprich","year":"2011","journal-title":"Psychooncology"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.032_bib0023","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0165-1781(91)90027-M","article-title":"Validity and reliability of a scale to assess fatigue","volume":"36","author":"Lee","year":"1991","journal-title":"Psychiatry Res"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.032_bib0024","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association","volume":"148","author":"Barry","year":"1992","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.032_bib0025","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.urology.2010.01.027","article-title":"Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors","volume":"76","author":"Szymanski","year":"2010","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.032_bib0026","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","article-title":"Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer","volume":"56","author":"Wei","year":"2000","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.032_bib0027","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0885-3924(01)00353-0","article-title":"The hot flash related daily interference scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer","volume":"22","author":"Carpenter","year":"2001","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.032_bib0028","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/jcm9030661","article-title":"Reliability and validity of the short-form 12 item version 2 (SF-12v2) health-related quality of life survey and disutilities associated with relevant conditions in the U.S. older adult population","volume":"9","author":"Shah","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.032_bib0029","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00001648-199601000-00014","article-title":"Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals","volume":"7","author":"Chasan-Taber","year":"1996","journal-title":"Epidemiology"},{"key":"10.1016\/j.urolonc.2021.05.032_bib0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1756-0500-5-187","article-title":"Comparison of two ActiGraph accelerometer generations in the assessment of physical activity in free living conditions","volume":"5","author":"Vanhelst","year":"2012","journal-title":"BMC Res Notes"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.032_bib0031","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.urology.2003.10.063","article-title":"Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer","volume":"63","author":"Smith","year":"2004","journal-title":"Urology"},{"issue":"9","key":"10.1016\/j.urolonc.2021.05.032_bib0032","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1161\/CIRCULATIONAHA.107.185649","article-title":"Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association","volume":"116","author":"Haskell","year":"2007","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.urolonc.2021.05.032_bib0033","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1249\/mss.0b013e3180616aa2","article-title":"Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association","volume":"39","author":"Nelson","year":"2007","journal-title":"Med Sci Sports Exerc"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921002532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921002532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:20:50Z","timestamp":1761042050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143921002532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1078143921002532"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.05.032","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multidisciplinary team-based approach with lifestyle modification and symptom management to address the impact of androgen deprivation therapy in prostate cancer: A randomized phase II study","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}